National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): Arthritis trials

The registry lists 24 Arthritis studies with National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 7No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pain Phenotyping of Rheumatic Diseases - An Observational StudyNot yet recruitingNCT07829497
• Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related ConditionsRecruitingNCT03510442
• Natural History and Development of SpondyloarthritisRecruitingNCT01422694
• Studies of the Natural History of Rheumatic DiseasesRecruitingNCT00024479
• Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)CompletedNCT00815425
• Juvenile Rheumatoid Arthritis Research RegistryCompletedNCT00090571
• Registry for African Americans With Early Rheumatoid ArthritisCompletedNCT00074555
• Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or SulfasalazineCompletedNCT00062465Phase 2
• Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal StudyCompletedNCT00056719
• Clinically Important Changes in Rheumatoid ArthritisCompletedNCT00056602
• The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With EtanerceptCompletedNCT00034060Phase 2
• Infliximab to Treat Children With Juvenile Rheumatoid ArthritisTerminatedNCT00029042Phase 2
• Positron Emission Tomography and Magnetic Resonance Imaging to Evaluate Synovial Blood Flow in Rheumatoid Arthritis PatientsCompletedNCT00014794Phase 1
• Study of Arthritis and Related ConditionsCompletedNCT00006333
• Infliximab for the Treatment of Early Rheumatoid ArthritisCompletedNCT00006292Phase 2
• Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis PatientsCompletedNCT00001679
• Genetics of Rheumatoid ArthritisCompletedNCT00001678
• Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and EfficacyCompletedNCT00001677Phase 2
• A Controlled Trial of Intermittent Fludarabine for Psoriatic ArthritisCompletedNCT00001422Phase 2
• Study of Psoriatic ArthritisCompletedNCT00001420
• Steroid Hormones, TH1/TH2 Cytokines and Reproductive StatusCompletedNCT00001376
• The Pathogenesis of Inflammatory Synovitis: A Study of Early ArthritisCompletedNCT00001375
• Genetic and Immune Studies of Rheumatoid Arthritis and Related ConditionsCompletedNCT00001291
• dnaJ Peptide for Relieving Rheumatoid ArthritisCompletedNCT00000435Phase 2